echemi logo
  • Product
  • Supplier
  • Inquiry
    Biochemistry News
    AbbVie's Rinvoq application for the treatment of moderate to severe atopic dermatitis has been delayed by the FDA

    CompilationFan DongdongA few days ago, the US FDA stated that it would postpone the decision date of Rinvoq's sNDA application for moderate to severe atopic dermatitis by 3 months.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.